Action Radiotherapy is supported and run by some of the most experienced UK and international radiotherapy specialists.
Professor Pat Price
She took up a research position under a Cancer Research Campaign Clinical Fellowship at the Institute of Cancer Research, London, and won the Cambridge University prize for best laboratory based MD. She then went on to work at the Hammersmith Hospital, London as a Senior Lecturer.
While at the Hammersmith Professor Price developed a research interest in molecular imaging for oncology and set up and headed the Medical Research Council and Cancer Research Campaign Positron Emission Tomography (PET) Oncology Programmes. She moved to Manchester in September 2000 to take up the Ralston Paterson Chair in Radiation Oncology and set up the new Wolfson Molecular Imaging Centre at the Christie Hospital. She is now Visiting Professor at Imperial College London.
Professor Malcolm Mason
Professor Malcolm Mason is a clinician who specialises in the management of urological cancers, in which capacity he is the Chairman of the UK National Cancer Research Institute’s Prostate Cancer Clinical Studies Group. He is an experienced Clinical Researcher, has been the Chief Investigator for a number of Medical Research Council trials, and he has over 250 publications in his field. For the UICC (International Union Against Cancer) he Chairs the UK TNM Committee, and sits on the Core Group and the Prognostic Factors Task Group. Since 2003 he has been the Director of the Wales Cancer Bank, the UK’s first population-based tumour and blood sample collection, which to date has recruited over 3,900 patients. He also has laboratory research interests in prostate cancer, focused on immunology and on cancer metastasis.
Ms Tanya Levine
Peter Zarko-Flynn is a media relations specialist with more than 25 years experience and is currently Director of Communications at Cancer Research UK. A former BBC News & Current Affairs producer, Peter has provided media relations advice to the UK’s leading health and science organisations, including the Francis Crick Institute, Imperial College London, the NHS National Cancer Action Team, Anthony Nolan, and NHS Blood & Transplant. He has been actively involved in raising awareness of radiotherapy since 2010.
Dr Christy Goldsmith
Dr Christy Goldsmith is a Clinical Oncologist specialising in an advanced radiotherapy technique called Stereotactic Body Radiotherapy (SBRT). She is a Committee Member on the SABR Consortium UK, a Consortium which has been active in advocating for access for patients to SBRT treatment, as well as developing treatment guidelines, and furthering UK SBRT research.
Dr Goldsmith has presented Internationally at Radiotherapy meetings (ASTRO/ESTRO/RSS) on outcomes of UK SBRT. She has also ran the British 10k London to fundraise for Action Radiotherapy.
Judith Potts is a former actress and current acting, voice and presentation coach. She writes speeches and presentations – often directing the latter.
She writes a (pro bono) Health Column for the Telegraph – principally about cancer and its attendant issues. She is the Founder of Esme’s Umbrella (www.charlesbonnetsyndrome.uk) – the Awareness Campaign for the little-known frightening, hallucinatory condition called Charles Bonnet Syndrome. The Campaign seeks to raise awareness amongst the medical profession and the community, to prevent those who develop the condition from suffering in silence with the word ‘dementia’ hanging above them. CBS is not a form of dementia but caused by deteriorating vision, which allows the brain to ‘fill in the blanks’ with images – which range from disturbing to terrifying.
She was diagnosed with breast cancer in 2008 for which she received a course of radiotherapy.
Stephen Adolphus practices Maritime law. He was an early member of Action Radiotherapy and was involved with the charity in the early stages. In addition to helping with fund raising, he provided legal advise to the charity.
Stephen takes an interest in all forms of cancer treatments but takes a particular interest in the new developments in focused radiotherapy. He has family members who have benefited from a course of radiotherapy. He recognises the huge breakthroughs that have been made in this area of modern non-invasive radiotherapy.